Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C-Reference-Cited by-同舟云学术

Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C

Published:2010-04 Issue:4 Volume:50 Page:434-449
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Hawke Roy L.,Schrieber Sarah J.,Soule Tedi A.,Wen Zhiming,Smith Philip C.,Reddy K. Rajender,Wahed Abdus S.,Belle Steven H.,Afdhal Nezam H.,Navarro Victor J.,Berman Josh,Liu Qi-Ying,Doo Edward,Fried Michael W.,

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference41 articles.

1. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

2. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

3. Peginterferon and ribavirin for chronic hepatitis C;Hoofnagle;N Engl J Med,2006

4. Treatment of chronic hepatitis C with PEGylated interferon and ribavirin;Cornberg;Curr Gastroenterol Rep,2002

5. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey;Eisenberg;JAMA,1998

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Silymarin as an Antioxidant Therapy in Chronic Liver Diseases: A Comprehensive Review;Cureus;2024-08-17

2. Natural Anticarcinogens: The Efficacy of Herbs and Spices;Herbs and Spices - New Perspectives in Human Health and Food Industry [Working Title];2024-06-27

3. Rifampin- and Silymarin-Mediated Pharmacokinetic Interactions of Exogenous and Endogenous Substrates in a Transgenic OATP1B Mouse Model;Molecular Pharmaceutics;2024-03-26

4. Clinically Effective Molecules of Natural Origin for Obesity Prevention or Treatment;International Journal of Molecular Sciences;2024-02-25

5. Silymarin: Unveiling its pharmacological spectrum and therapeutic potential in liver diseases—A comprehensive narrative review;Food Science & Nutrition;2024-02-16